Qingqing Wang

Qingqing Wang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
YLyingying li
yingying li
XHXia Hu
Xia Hu
ZDZhiyong Dong
Zhiyong Dong
YCYuanzheng Chen
Yuanzheng Chen
WZWeiman Zhao
Weiman Zhao
QWQingqing Wang
Qingqing Wang

19 November 2020 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
LZLu Zhang
Lu Zhang
YLyingying li
yingying li
FWFang Wei
Fang Wei
HLHang Liu
Hang Liu
YWYushuai Wang
Yushuai Wang
QWQingqing Wang
Qingqing Wang

19 December 2022 in Drug Delivery
Verified
Journal Article
Open access
WZWeiman Zhao
Weiman Zhao
LZLijie Zheng
Lijie Zheng
JYJianhui Yang
Jianhui Yang
ZMZihui Ma
Zihui Ma
XTXinyi Tao
Xinyi Tao
QWQingqing Wang
Qingqing Wang
Methotrexate (MTX) is a first-line treatment for rheumatoid arthritis (RA), but its clinical use is greatly limited by the adverse effects and poor patient compliance caused by traditional oral administration or injection. In recent years, some transdermal drug delivery systems have received considerable attention due to overcoming these shortcomings. In this study, we developed dissolving microneedle patch (DMNP) for transdermal delivery of MTX to treat RA safely and effectively. The morphology, mechanical strength, skin insertion, drug content, in vitro transdermal delivery, and other properties of DMNP were characterized. Meanwhile, the adjuvant-induced arthritis model of rats was established to investigate the therapeutic effect of MTX-loaded DMNP in vivo. The results showed that the microneedles had excellent morphology with neat array and complete needles, good puncture performance and mechanical strength, and rapid intradermal dissolution rate. In vitro transdermal delivery results indicated that microneedles could significantly increase drug transdermal permeation compared with the cream group. The pharmacological study showed that MTX-loaded DMNP significantly alleviated paw swelling, inhibit inflammatory response via downregulating the levels of TNF-α and IL-1β, relieved synovium destruction with less cartilage erosion, and slowed the progression of RA in AIA rats. Besides, DMNP presented better therapeutic performance than cream or intragastric administration at the same dosage of MTX. In conclusion, the MTX-loaded dissolving microneedle patch has advantages of safety, convenience, and high efficacy over conventional administrations, laying a foundation for the transdermal drug delivery system treatment of rheumatoid arthritis.

12 August 2022 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
QWQiuyue Wang
Qiuyue Wang
XYXuejing Yang
Xuejing Yang
XGXun Gu
Xun Gu
FWFang Wei
Fang Wei
WCWenyu Cao
Wenyu Cao
QWQingqing Wang
Qingqing Wang

10 May 2023 in Biosensors
Verified
Journal Article
Open access
PDF file
QZQingya Zeng
Qingya Zeng
MXMengxin Xu
Mengxin Xu
WHWeilun Hu
Weilun Hu
WCWenyu Cao
Wenyu Cao
YZYujie Zhan
Yujie Zhan
TMTao Ma
Tao Ma
Though monitoring blood glucose (BG) is indispensable for regulating diabetes, the frequent pricking of the finger by the commonly used fingertip blood collection causes discomfort and poses an infection risk. Since glucose levels in skin interstitial fluid (ISF) correlate with blood glucose levels, monitoring glucose in the skin ISF can be a viable alternative. With this rationale, the present study developed a biocompatible porous microneedle capable of rapid sampling, sensing, and glucose analysis in ISF in a minimally invasive manner, which can improve patient compliance and detection efficiency. The microneedles contain glucose oxidase (GOx) and horseradish peroxidase (HRP), and a colorimetric sensing layer containing 3,3′,5,5′-tetramethylbenzidine (TMB) is on the back of the microneedles. After penetrating rat skin, porous microneedles harvest ISF rapidly and smoothly via capillary action, triggering the production of hydrogen peroxide (H2O2) from glucose. In the presence of H2O2, HRP reacts with TMB contained in the filter paper on the back of microneedles, causing an easily visible color shift. Further, a smartphone analysis of the images quickly quantifies glucose levels in the 50–400 mg/dL range using the correlation between color intensity and glucose concentration. The developed microneedle-based sensing technique with minimally invasive sampling will have great implications for point-of-care clinical diagnosis and diabetic health management.

5 March 2023 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
WZWeiman Zhao
Weiman Zhao
LZLijie Zheng
Lijie Zheng
JYJianhui Yang
Jianhui Yang
YLYingying Li
Yingying Li
YZYueyue Zhang
Yueyue Zhang
QWQingqing Wang
Qingqing Wang
Recently, transdermal treatment of rheumatoid arthritis (RA) has received increasing attention due to the advantages of improving patient compliance and avoiding gastrointestinal side effects. However, the stratum corneum (SC) barrier limits the transdermal delivery of most substances. Therefore, we constructed tetramethylpyrazine-loaded dissolving microneedle patches (TMP-DMNPs) and investigated its anti-rheumatoid arthritis effect. The cone-shaped dissolving microneedle patch had complete, neatly arranged needles and great mechanical strength. It could effectively penetrate the stratum corneum when applied to the skin. In vitro transdermal experiment showed that DMNPs could significantly promote the transdermal penetration of TMP compared with TMP-cream. The needles were completely dissolved within 18 min and the applied skin recovered completely within 3 h. The excipients and blank DMNP had good safety and biocompatibility to human rheumatoid arthritis fibroblast synovial cells. To compare the therapeutic effects, the animal model was established. The experiments of paw swelling, histopathology and X-ray examination showed that dissolving microneedles significantly alleviated paw condition, reduced the serum concentrations of proinflammatory cytokines, and inhibited synovial tissue damage in AIA rats. These results indicate that the DMNPs we prepared can deliver TMP safely, effectively and conveniently, providing a basis for the percutaneous treatment of RA.